Clinical trial
Effects of GLP-1 Receptor Agonists Combined with Metformin and Healthy Lifestyle Education Prior to Fertility Treatment on Reproductive Outcomes in Women with PCOS and Obesity
NCT06775093 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of GLP-1 Receptor Agonists Combined with Metformin and Healthy Lifestyle Education Prior to Fertility Treatment on Reproductive Outcomes in Women with PCOS and Obesity
- Lead sponsor
- Peking University Third Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 1, 2025
- Completion date
- December 31, 2027
- Enrollment
- 392 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.